Maximizing Real-World Survival: Biomarker Testing in NSCLC
Explore the impact of biomarker testing in metastatic NSCLC. This whitepaper demonstrates how guideline-based testing and targeted therapies significantly improve survival, offering actionable insights to enhance outcomes and address disparities in care.
jpiatt
Tue, 09/09/2025 – 21:20
This whitepaper demonstrates how guideline-based testing and targeted therapies significantly improve survival, offering actionable insights to enhance outcomes and address disparities in care.
Resource Type
Tue, 09/09/2025 – 08:00
Landing Page Url